For: | Berger BM, Levin B, Hilsden RJ. Multitarget stool DNA for colorectal cancer screening: A review and commentary on the United States Preventive Services Draft Guidelines. World J Gastrointest Oncol 2016; 8(5): 450-458 [PMID: 27190584 DOI: 10.4251/wjgo.v8.i5.450] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v8/i5/450.htm |
Number | Citing Articles |
1 |
Cédric Rat, Chloé Latour, Rosalie Rousseau, Aurélie Gaultier, Corinne Pogu, Adrian Edwards, Jean-Michel Nguyen. Interventions to increase uptake of faecal tests for colorectal cancer screening: a systematic review. European Journal of Cancer Prevention 2018; 27(3): 227 doi: 10.1097/CEJ.0000000000000344
|
2 |
Wen-Sy Tsai, Jeng-Fu You, Hsin-Yuan Hung, Pao-Shiu Hsieh, Ben Hsieh, Heinz-Josef Lenz, Gregory Idos, Shai Friedland, Jennifer Yi-Jiun Pan, Hung-Jen Shao, Jen-chia Wu, Jr-Ming Lai, Shih-En Chang, Rui Mei, Drew Watson, Manana Javey, Ashish Nimgaonkar. Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer. Clinical and Translational Gastroenterology 2019; 10(10): e00088 doi: 10.14309/ctg.0000000000000088
|
3 |
Rasika Mundade, Thomas F. Imperiale, Lakshmi Prabhu, Patrick J. Loehrer, Tao Lu. Genetic pathways, prevention, and treatment of sporadic colorectal cancer. Oncoscience 2014; 1(6): 400 doi: 10.18632/oncoscience.59
|
4 |
Jennifer Beane, Joshua D Campbell, Julian Lel, Jessica Vick, Avrum Spira. Genomic approaches to accelerate cancer interception. The Lancet Oncology 2017; 18(8): e494 doi: 10.1016/S1470-2045(17)30373-X
|
5 |
Raquel Gómez-Molina, Miguel Suárez, Raquel Martínez, Marifina Chilet, Josep Miquel Bauça, Jorge Mateo. Utility of Stool-Based Tests for Colorectal Cancer Detection: A Comprehensive Review. Healthcare 2024; 12(16): 1645 doi: 10.3390/healthcare12161645
|
6 |
|
7 |
Zbigniew Banaszkiewicz, Jacek Budzyński, Krzysztof Tojek, Paweł Jarmocik, Jacek Frasz, Marcin Mrozowski, Maciej Świtoński, Arkadiusz Jawień. The fecal occult blood test as a tool for improved outpatient qualification for colonoscopy. A single-center experience and 10-year follow-up survey. Advances in Medical Sciences 2017; 62(1): 171 doi: 10.1016/j.advms.2016.08.003
|
8 |
Shaheen S. Kurani, Rozalina G. McCoy, Michelle A. Lampman, Chyke A. Doubeni, Lila J. Finney Rutten, Jonathan W. Inselman, Rachel E. Giblon, Kari S. Bunkers, Robert J. Stroebel, David Rushlow, Sagar S. Chawla, Nilay D. Shah. Association of Neighborhood Measures of Social Determinants of Health With Breast, Cervical, and Colorectal Cancer Screening Rates in the US Midwest. JAMA Network Open 2020; 3(3): e200618 doi: 10.1001/jamanetworkopen.2020.0618
|
9 |
Seth Sweetser, David A Ahlquist. Utility of the multitarget stool DNA test for detection of colorectal neoplasia. Colorectal Cancer 2017; 6(3): 83 doi: 10.2217/crc-2017-0010
|
10 |
Jiayi Mu, Yanqin Huang, Shanrong Cai, Qilong Li, Yongmao Song, Ying Yuan, Suzhan Zhang, Shu Zheng. Plausibility of an extensive use of stool DNA test for screening advanced colorectal neoplasia. Clinica Chimica Acta 2020; 501: 42 doi: 10.1016/j.cca.2019.12.001
|
11 |
Marina A Emelyanova, Anna Y Ikonnikova. Utilization of molecular genetic approaches for colorectal cancer screening. World Journal of Gastroenterology 2024; 30(46): 4950-4957 doi: 10.3748/wjg.v30.i46.4950
|
12 |
Parisa Rokni, Afsaneh Mojtabanezhad Shariatpanahi, Ebrahim Sakhinia, Mohammad Amin Kerachian. BMP3 promoter hypermethylation in plasma-derived cell-free DNA in colorectal cancer patients. Genes & Genomics 2018; 40(4): 423 doi: 10.1007/s13258-017-0644-2
|
13 |
Maleesha Jayasinghe, Omesh Prathiraja, Dilushini Caldera, Rahul Jena, James Anwar Coffie-Pierre, Minollie Suzanne Silva, Ozair S Siddiqui. Colon Cancer Screening Methods: 2023 Update. Cureus 2023; doi: 10.7759/cureus.37509
|
14 |
Melanie Tepus, Tung On Yau. Non-Invasive Colorectal Cancer Screening: An Overview. Gastrointestinal Tumors 2020; 7(3): 62 doi: 10.1159/000507701
|
15 |
Tomoyuki Handa, Masatake Kuroha, Hiroshi Nagai, Yusuke Shimoyama, Takeo Naito, Rintaro Moroi, Yoshitake Kanazawa, Hisashi Shiga, Yoichi Kakuta, Yoshitaka Kinouchi, Atsushi Masamune. Liquid Biopsy for Colorectal Adenoma: Is the Exosomal miRNA Derived From Organoid a Potential Diagnostic Biomarker?. Clinical and Translational Gastroenterology 2021; 12(5): e00356 doi: 10.14309/ctg.0000000000000356
|
16 |
Adhara Brandão Lima, Mariana Bisarro dos Reis, Marcus Matsushita, Monise Tadin dos Reis, Marco Antônio de Oliveira, Rui Manuel Reis, Denise Peixoto Guimarães. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population. Cancer Medicine 2023; 12(15): 15854 doi: 10.1002/cam4.6224
|
17 |
Seyed Mohammad Amin Kormi, Shima Ardehkhani, Mohammad Amin Kerachian. New insights into colorectal cancer screening and early detection tests. Colorectal Cancer 2017; 6(2): 63 doi: 10.2217/crc-2017-0007
|
18 |
Ryan Wai-Yan Sin, Dominic Chi-Chung Foo, Deepak Narayanan Iyer, May Sau-Yee Fan, Xue Li, Oswens Siu-Hung Lo, Wai-Lun Law, Lui Ng, Ludovic Zimmerlin. A Pilot Study Investigating the Expression Levels of Pluripotency-Associated Genes in Rectal Swab Samples for Colorectal Polyp and Cancer Diagnosis and Prognosis. Stem Cells International 2021; 2021: 1 doi: 10.1155/2021/4139528
|
19 |
David Coleman, Scott Kuwada. miRNA as a Biomarker for the Early Detection of Colorectal Cancer. Genes 2024; 15(3): 338 doi: 10.3390/genes15030338
|